生物
异型生物质的
微生物群
肠道菌群
药物代谢
药品
肠道微生物群
微生物生态学
功能(生物学)
生物利用度
微生物代谢
人体微生物群
共生
计算生物学
药理学
生物信息学
酶
免疫学
细菌
遗传学
生物化学
作者
Archana Pant,Tushar Kanti Maiti,Dinesh Mahajan,Bhabatosh Das
出处
期刊:Microbial Ecology
[Springer Science+Business Media]
日期:2022-07-23
卷期号:86 (1): 97-111
被引量:93
标识
DOI:10.1007/s00248-022-02081-x
摘要
The efficacy of drugs widely varies in individuals, and the gut microbiota plays an important role in this variability. The commensal microbiota living in the human gut encodes several enzymes that chemically modify systemic and orally administered drugs, and such modifications can lead to activation, inactivation, toxification, altered stability, poor bioavailability, and rapid excretion. Our knowledge of the role of the human gut microbiome in therapeutic outcomes continues to evolve. Recent studies suggest the existence of complex interactions between microbial functions and therapeutic drugs across the human body. Therapeutic drugs or xenobiotics can influence the composition of the gut microbiome and the microbial encoded functions. Both these deviations can alter the chemical transformations of the drugs and hence treatment outcomes. In this review, we provide an overview of (i) the genetic ecology of microbially encoded functions linked with xenobiotic degradation; (ii) the effect of drugs on the composition and function of the gut microbiome; and (iii) the importance of the gut microbiota in drug metabolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI